Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey.

ABSTRACT:

Background

During the current SARS-CoV-2 pandemic it is important to identify risk factors for COVID-19. Registry studies are providing growing evidence on the elevated risk of mortality from COVID-19 in patients with chronic liver disease, especially in advanced stages. Results may, however, have a selection bias towards severe cases. Limited data is available on COVID-19 in patients with autoimmune liver disease (AILD).

Aim

To perform an online survey to capture the prevalence of COVID-19 and the state of medical care of patients with AILD in Europe during the pandemic.

Methods

Data was collected via an anonymous patient-oriented, online survey, which was available on the EUSurvey platform in nine European languages between 24^th June 2020 and 14^th

SUBMITTER: Zecher BF 

PROVIDER: S-EPMC8242670 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature